Distal tibia allograft reconstruction yielded outcomes similar to Latarjet
TORONTO — Patients who underwent distal tibia allograft reconstruction had similar clinical outcomes, complication and recurrence rates compared with patients who underwent the Latarjet procedure, according to a paper that won the Fellows Clinical Science Research Award at the American Orthopaedic Society for Sports Medicine Annual Meeting.
Rachel M. Frank, MD, and colleagues collected intraoperative and postoperative data on patients with recurrent anterior shoulder instability and a minimum 15% glenoid bone loss treated with either a Latarjet procedure (n=50) or a distal tibia allograft (n=50).
Frank noted significant improvements in all clinical outcome scores assessed at a minimum of 2-year follow-up, with the only difference between the two groups identified with the simple shoulder test. One case of traumatic recurrence was identified in the distal tibia group, according to Frank.
“There were 10 total complications, five in each group, and there were no significant differences between the groups with regard to the complications,” Frank said in her presentation. “In the distal tibia group, three patients required reoperation including on revision distal tibia allograft. In the Latarjet group, three patients also required reoperation.” – by Casey Tingle
Frank RM, et al. Paper #168. Presented at: American Orthopaedic Society for Sports Medicine Annual Meeting; July 20-23, 2017; Toronto.
Disclosure: Frank reports no relevant financial disclosures.